{"id":"dec24d526b40","type":"article","url":"https://hartvaat.nl/2026/02/01/richtlijnnaleving-bij-myocardinfarctbehandeling-reactie/","title":"Richtlijnnaleving bij myocardinfarctbehandeling — reactie","title_en":"Guideline Adherence in Myocardial Infarction Treatment—Reply","category":"algemeen","category_label":"Algemeen","professions":["cardioloog"],"tags":["hypertrofische-cardiomyopathie","myocardinfarct"],"journal":"JAMA Cardiology","doi":"https://jamanetwork.com/journals/jamacardiology/fullarticle/2843038","source_url":"https://doi.org/https://jamanetwork.com/journals/jamacardiology/fullarticle/2843038","authors":[],"significance":4,"published":"2026-02-01","source_date":"2026-02-01","image":"","kennis":["https://hartvaat.nl/kennis/coronairlijden/stemi/"],"congress":"","summary_en":"The authors reply to correspondence regarding challenges in achieving timely reperfusion in STEMI patients and the role of guideline adherence in myocardial infarction treatment.","created":"2026-07-03T10:25:28Z","updated":"2026-07-03T13:24:52Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Reactie van de auteurs op ingezonden brieven over de aanhoudende uitdagingen bij het bereiken van tijdige reperfusie bij STEMI-patiënten en de rol van richtlijnnaleving.","abstract_original":"In Reply We appreciate the authors’ thoughtful comments and share their concern regarding the persistent challenges in achieving timely reperfusion in patients with ST-elevation myocardial infarction (STEMI). As they rightly note, timely revascularization, whether through primary percutaneous coronary intervention (pPCI) or pharmacoinvasive therapy, remains critical for survival."}